Enteral Omega 3 During Radiotherapy to Improve the Quality of Life and Functionality of Head and Neck Cancer Patients

NCT03720158 · clinicaltrials.gov ↗

Phase

TERMINATED

Status

Enrollment

OTHER_GOV

Sponsor class

Stopped The activities in the study hospital were seriously impacted by the medical care of COVID patients, affecting the medical management protocol of the study population. This situation does not allow to continue with the recruitment of patients.

Conditions

Head and Neck Squamous Cell Carcinoma
Quality of Life
Radiotherapy; Complications

Interventions

DIETARY_SUPPLEMENT: Omega 3 Group
DIETARY_SUPPLEMENT: Placebo or Control Group

Sponsor

Coordinación de Investigación en Salud, Mexico